AEON Biopharma Inc [AMEX: AEON] price plunged by -63.09 percent to reach at -$0.36.
The one-year AEON stock forecast points to a potential upside of 95.8. The average equity rating for AEON stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on AEON Biopharma Inc [AEON]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AEON shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AEON stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for AEON Biopharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 18, 2023.
AEON Stock Performance Analysis:
AEON Biopharma Inc [AEON] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -64.41. With this latest performance, AEON shares dropped by -68.66% in over the last four-week period, additionally sinking by -79.41% over the last 6 months – not to mention a drop of -97.29% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AEON stock in for the last two-week period is set at 23.45, with the RSI for the last a single of trading hit 16.57, and the three-weeks RSI is set at 28.36 for AEON Biopharma Inc [AEON]. The present Moving Average for the last 50 days of trading for this stock 0.6833, while it was recorded at 0.4858 for the last single week of trading, and 2.0458 for the last 200 days.
Insight into AEON Biopharma Inc Fundamentals:
AEON Biopharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.22 and a Current Ratio set at 0.22.
AEON Biopharma Inc [AEON] Institutonal Ownership Details
There are presently around $33.14%, or 51.98%% of AEON stock, in the hands of institutional investors.
